INITIAL SCREEN TESTING AND RESULTS Sample Clauses

INITIAL SCREEN TESTING AND RESULTS. Screen testing is alcohol screening (breathalyser) in conjunction with saliva sample for drug testing. A Independent Tester will conduct an initial Screen test for: • all Random tests, • Cause tests, and These tests will be performed in accordance with the testing equipment manufacturer’s specifications. Individuals will be provided with and must take the opportunity at the time the sample is collected, to declare any information which they consider relevant to the test. Section 10 of this Policy has further detail on declaring information regarding prescribed and Over The Counter (OTC) medications, the influence that this may have on a test result, and how that result will be viewed. If the initial Screen test for alcohol and drugs is negative, no further action is required and the person may immediately present for work. If the initial Screen test result is non-negative for drugs, the person may elect to have a 2nd (verification) Screen test conducted from the same sample used for the initial Screen test. If the verification Screen test is negative, they may continue to access site and present for work. If both Screen test results are non-negative for drugs, the person will be deemed as not fit-for-work pending the result of the Confirmatory test. The individual must notify their Supervisor that they will not be attending for work that day / shift. The individual will be sent home by suitable transport (at their own cost) on the appropriate type of leave (as defined in Table 1). The individual will need to present for a Clearance test at the commencement of their next scheduled shift. Contractors will be denied access to site until they pass a Clearance test, and their employer advised by the Business Unit Manager or Regional General Manager that they have failed the fitness for work criteria at Capral.
Sample 1
AutoNDA by SimpleDocs

Related to INITIAL SCREEN TESTING AND RESULTS

  • BID TABULATION AND RESULTS Bid tabulations shall be available thirty (30) days after opening on the Orange County website at: xxxx://xxxx.xxxx.xxx/orangebids/bidresults/results.asp or upon notice of intended action, whichever is sooner.

  • Test Results The employer, upon request from an employee or former employee, will provide the confidential written report issued pursuant to 4.9 of the Canadian Model in respect to that employee or former employee.

  • Positive Test Results In the event an employee tests positive for drug use, the employee will be provided, in writing, notice of their right to explain the test results. The employee may indicate any relevant circumstance, including over the counter or prescription medication taken within the last thirty (30) days, or any other information relevant to the reliability of, or explanation for, a positive test result.

  • Research Independence The Company acknowledges that each Underwriter’s research analysts and research departments, if any, are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriter’s research analysts may hold and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of its investment bankers. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against such Underwriter with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriter’s investment banking divisions. The Company acknowledges that the Representative is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short position in debt or equity securities of the Company.

  • Research Analyst Independence The Company acknowledges that the Underwriters’ research analysts and research departments are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal policies, and that such Underwriters’ research analysts may hold views and make statements or investment recommendations and/or publish research reports with respect to the Company and/or the offering that differ from the views of their respective investment banking divisions. The Company hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters with respect to any conflict of interest that may arise from the fact that the views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or advice communicated to the Company by such Underwriters’ investment banking divisions. The Company acknowledges that each of the Underwriters is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short positions in debt or equity securities of the companies that may be the subject of the transactions contemplated by this Agreement.

  • Development Records Each Party shall maintain complete, current and accurate records of all Development activities conducted by it hereunder, and all data and other information resulting from such activities. Such records shall fully and properly reflect all work done and results achieved in the performance of the Development activities in good scientific manner appropriate for regulatory and patent purposes. Each Party shall document all non-clinical studies and Clinical Trials in formal written study reports according to Applicable Laws and national and international guidelines (e.g., ICH, cGCP, cGLP, and cGMP).

  • COVID-19 Vaccine Passports Pursuant to Texas Health and Safety Code, Section 161.0085(c), Contractor certifies that it does not require its customers to provide any documentation certifying the customer’s COVID-19 vaccination or post-transmission recovery on entry to, to gain access to, or to receive service from the Contractor’s business. Contractor acknowledges that such a vaccine or recovery requirement would make Contractor ineligible for a state-funded contract.

  • Technology Research Analyst Job# 1810 General Characteristics

  • Curriculum Development This includes the analysis and coordination of textual materials; constant review of current literature in the field, some of which are selected for the college library collection, the preparation of selective, descriptive materials such as outlines and syllabi; conferring with other faculty and administration on curricular problems; and, the attendance and participation in inter and intra-college conferences and advisory committees.

  • Target Population TREATMENT FOR ADULT (TRA) Target Population

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!